Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christine E Engeland

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Molecular Therapy. Methods & Clinical Development|October 10, 2022
Safety study supports clinical development of immunotherapeutic oncolytic measles vaccineChristine E Engeland
Cancer Biotherapy & Radiopharmaceuticals|December 1, 2020
Re: "Oncolytic Measles Virus Encoding Interleukin-12 Mediated Antitumor Activity and Immunologic Control of Colon Cancer <i>In Vivo</i> and <i>Ex Vivo</i>" by Wang et alChristine E Engeland
Methods in Molecular Biology (Clifton, N.J.)|September 6, 2019
Immunomodulation in Oncolytic Measles VirotherapyLaura Dietz, Christine E Engeland
Methods in Molecular Biology (Clifton, N.J.)|June 22, 2022
NK Cell Effector Functions and Bystander Tumor Cell Killing in ImmunovirotherapyAlessia Floerchinger, Christine E Engeland
Cancers|February 4, 2021
Measles Virus as an Oncolytic ImmunotherapyChristine E Engeland, Guy Ungerechts
Cytokine & Growth Factor Reviews|July 15, 2020
Mechanisms of measles virus oncolytic immunotherapyGemma Pidelaserra-Martí, Christine E Engeland
Methods in Molecular Biology (Clifton, N.J.)|September 6, 2019
Introduction to Oncolytic VirotherapyChristine E Engeland, John C Bell
Journal of Visualized Experiments : Jove|January 22, 2019
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex VivoJohannes P W Heidbuechel, Christine E Engeland
Journal of Hematology & Oncology|April 17, 2021
Oncolytic viruses encoding bispecific T cell engagers: a blueprint for emerging immunovirotherapiesJohannes P W Heidbuechel, Christine E Engeland
Frontiers in Immunology|November 29, 2023
Editorial: Rising stars in cancer immunity and immunotherapy 2022Cleo Goyvaerts, Christine E Engeland, Kevin Van der Jeught
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Molecular Therapy. Methods & Clinical Development|October 10, 2022
Safety study supports clinical development of immunotherapeutic oncolytic measles vaccineChristine E Engeland
Cancer Biotherapy & Radiopharmaceuticals|December 1, 2020
Re: "Oncolytic Measles Virus Encoding Interleukin-12 Mediated Antitumor Activity and Immunologic Control of Colon Cancer <i>In Vivo</i> and <i>Ex Vivo</i>" by Wang et alChristine E Engeland
Methods in Molecular Biology (Clifton, N.J.)|September 6, 2019
Immunomodulation in Oncolytic Measles VirotherapyLaura Dietz, Christine E Engeland
Methods in Molecular Biology (Clifton, N.J.)|June 22, 2022
NK Cell Effector Functions and Bystander Tumor Cell Killing in ImmunovirotherapyAlessia Floerchinger, Christine E Engeland
Cancers|February 4, 2021
Measles Virus as an Oncolytic ImmunotherapyChristine E Engeland, Guy Ungerechts
Cytokine & Growth Factor Reviews|July 15, 2020
Mechanisms of measles virus oncolytic immunotherapyGemma Pidelaserra-Martí, Christine E Engeland
Methods in Molecular Biology (Clifton, N.J.)|September 6, 2019
Introduction to Oncolytic VirotherapyChristine E Engeland, John C Bell
Journal of Visualized Experiments : Jove|January 22, 2019
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex VivoJohannes P W Heidbuechel, Christine E Engeland
Journal of Hematology & Oncology|April 17, 2021
Oncolytic viruses encoding bispecific T cell engagers: a blueprint for emerging immunovirotherapiesJohannes P W Heidbuechel, Christine E Engeland
Frontiers in Immunology|November 29, 2023
Editorial: Rising stars in cancer immunity and immunotherapy 2022Cleo Goyvaerts, Christine E Engeland, Kevin Van der Jeught
Pageof 4